ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Long-Term Safety in Epstein-Barr Virus (EBV)-Seropositive Kidney-Only Transplant Recipients Treated with Belatacept (BELA) in Clinical Practice: Final Study Results from the ENLiST Registry

    C. Larsen1, F. Vincenti2, T. Kou3, C. Shadur4, B. Bresnahan5, S. Jordan6, E. S. Woodle7, N. Goes8, J. Vella9, D. Wojciechowski10, M. Polinsky3, A. Gomez-Caminero3

    1Emory University Transplant Center, Atlanta, GA, 2UCSF Transplant Center, San Francisco, CA, 3Bristol-Myers Squibb, Princeton, NJ, 4Iowa Kidney Physicians, Des Moines, IA, 5Medical College of Wisconsin, Milwaukee, WI, 6Cedars-Sinai Medical Center, Los Angeles, CA, 7University of Cincinnati, Cincinnati, OH, 8Kaiser Permanente, San Francisco, CA, 9Maine Nephrology Associates, PA, Portland, ME, 10University Hospital Kidney and Liver Transplant Clinic, Dallas, TX

    *Purpose: BELA, a selective T-cell costimulation blocker, is approved for the prophylaxis of organ rejection in EBV-seropositive adult kidney transplant recipients. In phase 3 BENEFIT…
  • 2020 American Transplant Congress

    Frequency and Main Diagnoses of Hospitalizations in Patients after Kidney Transplantation

    W. Duettmann-Rehnolt, P. Glander, P. Bach, F. Halleck, V. Graf, L. Lehner, M. Duerr, M. Mayrdorfer, K. Budde, M. Naik

    Nephrology, Charité-Universitätsmedizin Berlin, Berlin, Germany

    *Purpose: Kidney transplant recipients (KTR) suffer many complications and are hospitalized frequently. Specific reasons for hospital admission with detailed information are scarce.*Methods: We retrieved data…
  • 2020 American Transplant Congress

    Increased Transplant Surgery Advanced Practice Provider Involvement Associated with Decreased Hospital Length of Stay and Readmissions Following Kidney Transplantation

    E. A. Herriman1, J. R. Montgomery2, K. J. Brown1, K. J. Woodside1

    1Surgery-Section of Transplantation, University of Michigan, Ann Arbor, MI, 2Surgery, University of Michigan, Ann Arbor, MI

    *Purpose: Transplant surgery Advanced Practice Providers (APPs) are utilized to provide complex care to transplant patients. Daily responsibilities of APPs are broad and variable across…
  • 2020 American Transplant Congress

    Evaluation of the Economic Impact of a New IVD Immunoassay (Immunobiogram) for Immunosuppressive Treatment Adjustment in Kidney Transplant Recipients in Spain

    C. Rubio1, C. Jiménez2, M. Crespo3, J. Portolés4, D. Rubio1, T. Diez5, I. Portero5

    1Health Value, Madrid, Spain, 2La Paz Hospital, Madrid, Spain, 3Consorci Mar Parc de Salut, Barcelona, Spain, 4Puerta de Hierro Mahadahonda Hospital, Madrid, Spain, 5Biohope Scientific Solutions for Human Health SL, Madrid, Spain

    *Purpose: Immunobiogram (IMBG) is a new IVD bioassay developed by Biohope SL with the aim to support clinicians in the personalized adjustment of immunosuppressive therapy…
  • 2020 American Transplant Congress

    The Use of Scribes in Transplant Practice to Achieve Quality Outcomes and Foster Program Development

    M. Debroy, K. Chavin

    University Hospitals, Cleveland, OH

    *Purpose: Transplantation is the most regulated surgical specialty in the US today. Transplant Centers (TC) are an increasingly pivotal component contributing to the fiscal viability…
  • 2020 American Transplant Congress

    PHS High Risk: Is this Classification Still Needed?

    L. G. Smith

    Vanderbilt Transplant Center, Nashville, TN

    *Purpose: The continued shortage of organs for the over 100,000 candidates on the waitlist has led transplant centers to consider organs that have historically higher…
  • 2020 American Transplant Congress

    Impact of Patients’ Perception of Hospital Experience on Organ Donation Rates

    A. Azim1, A. Friedman2, S. Nishida1, K. Okumura1, G. Veillette1, T. Diflo1, R. Latifi1, H. Sogawa1

    1Surgery, Westchester Medical Center, Valhalla, NY, 2Transplant, Live On NY, New York, NY

    *Purpose: The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey is a validated data collection methodology for measuring a patient’s perception of his/her…
  • 2020 American Transplant Congress

    The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic

    B. Valdepenas, D. Choi, J. Benken, M. Campara

    Pharmacy Practice and Transplant Surgery, University of Illinois at Chicago, Chicago, IL

    *Purpose: The Centers for Medicare and Medicaid Services’ interpretative guidelines for conditions of participation for transplant centers define the transplant pharmacist’s role ambiguously. Limited evidence…
  • 2020 American Transplant Congress

    Accommodating Increasing Volumes without Knocking Down Walls: Update on an Infusion Center’s Growth

    J. C. Estrada

    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA

    *Purpose: An increase in transplants performed at the medical center in comparison to the limited availability of outpatient infusion chairs and home infusion companies compelled…
  • 2020 American Transplant Congress

    The 1-Year Incremental Costs of Delayed Graft Function (DGF) in Commercially Insured Kidney Transplant Patients Under 65

    T. Mayne1, F. Corvino2, A. Dillon2, W. Wang2, S. Mohan3

    1Angion Biomedica Corp, San Francisco, CA, 2Genesis Research, Hoboken, NJ, 3Columbia University Medical Center, New York, NY

    *Purpose: Strong evidence exists that DGF is associated with poor patient outcomes. The long-term impact of DGF on health resource use and cost, however, is…
  • « Previous Page
  • 1
  • …
  • 522
  • 523
  • 524
  • 525
  • 526
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences